-
1
-
-
70349430938
-
Bile acids: Regulation of synthesis
-
Chiang JY. Bile acids: regulation of synthesis. J Lipid Res 2009;50:1955-1966.
-
(2009)
J Lipid Res
, vol.50
, pp. 1955-1966
-
-
Chiang, J.Y.1
-
2
-
-
58249110568
-
Role of bile acids and bile Acid receptors in metabolic regulation
-
Lefebvre P, Cariou B,Lien F, Kuipers F, Staels B. Role of bile acids and bile Acid receptors in metabolic regulation. Physiol Rev 2009;89:147-191.
-
(2009)
Physiol Rev
, vol.89
, pp. 147-191
-
-
Lefebvre, P.1
Cariou Blien, F.2
Kuipers, F.3
Staels, B.4
-
3
-
-
34347401852
-
Bile acid sequestrants and the treatment of type 2 diabetes mellitus
-
Staels B, Kuipers F. Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Drugs 2007;67:1383-1392.
-
(2007)
Drugs
, vol.67
, pp. 1383-1392
-
-
Staels, B.1
Kuipers, F.2
-
4
-
-
33645098531
-
Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: A scientific review
-
Insull W Jr. Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review. South Med J 2006;99:257-273.
-
(2006)
South Med J
, vol.99
, pp. 257-273
-
-
Insull Jr., W.1
-
5
-
-
23044439087
-
Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia
-
Donovan JM, Von BK, Setchell KD, Isaacsohn J, Pappu AS, Illingworth DR, et al. Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia. Dig Dis Sci 2005;50:1232-1238.
-
(2005)
Dig Dis Sci
, vol.50
, pp. 1232-1238
-
-
Donovan, J.M.1
Von Bk Setchell, K.D.2
Isaacsohn, J.3
Pappu, A.S.4
Illingworth, D.R.5
-
6
-
-
54049103635
-
Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: Glucose and lipid effects
-
Bays HE, Goldberg RB, Truitt KE, Jones MR. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects. Arch Intern Med 2008;168:1975-1983.
-
(2008)
Arch Intern Med
, vol.168
, pp. 1975-1983
-
-
Bays, H.E.1
Goldberg, R.B.2
Truitt, K.E.3
Jones, M.R.4
-
7
-
-
49649095014
-
Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy
-
Fonseca VA, Rosenstock J, Wang AC, Truitt KE, Jones MR. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy. Diabetes Care 2008;31:1479-1484.
-
(2008)
Diabetes Care
, vol.31
, pp. 1479-1484
-
-
Fonseca, V.A.1
Rosenstock, J.2
Wang, A.C.3
Truitt, K.E.4
Jones, M.R.5
-
8
-
-
33947120281
-
Results of the glucose-lowering effect of WelChol study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes
-
Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes. Clin Ther 2007;29:74-83.
-
(2007)
Clin Ther
, vol.29
, pp. 74-83
-
-
Zieve, F.J.1
Kalin, M.F.2
Schwartz, S.L.3
Jones, M.R.4
Bailey, W.L.5
-
9
-
-
0020074674
-
Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides
-
Beil U, Crouse JR, Einarsson K, Grundy SM. Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides. Metabolism 1982;31:438-444.
-
(1982)
Metabolism
, vol.31
, pp. 438-444
-
-
Beil, U.1
Crouse, J.R.2
Einarsson, K.3
Grundy, S.M.4
-
10
-
-
0023624926
-
Hypertriglyceridemia: A contraindication to the use of bile acid binding resins
-
Crouse JR III. Hypertriglyceridemia: a contraindication to the use of bile acid binding resins. Am J Med 1987;83:243-248.
-
(1987)
Am J Med
, vol.83
, pp. 243-248
-
-
Crouse III, J.R.1
-
11
-
-
0018132578
-
Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia
-
Angelin B, Einarsson K, Hellstrom K, Leijd B. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. J Lipid Res 1978;19:1017-1024. (Pubitemid 9059813)
-
(1978)
Journal of Lipid Research
, vol.19
, Issue.8
, pp. 1017-1024
-
-
Angelin, B.1
Einarsson, K.2
Hellstrom, K.3
Leijd, B.4
-
12
-
-
0019851145
-
Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias. A controlled double-blind trial
-
Carulli N, Ponz de LM, Podda M, Zuin M, Strata A, Frigerio G, et al. Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias. A controlled double-blind trial. J Clin Pharmacol 1981;21:436-442.
-
(1981)
J Clin Pharmacol
, vol.21
, pp. 436-442
-
-
Carulli, N.1
Ponz De, L.M.2
Podda, M.3
Zuin, M.4
Strata, A.5
Frigerio, G.6
-
13
-
-
34248392648
-
Bile acids, farnesoid X receptor, atherosclerosis and metabolic control
-
Kuipers F, Stroeve JH, Caron S, Staels B. Bile acids, farnesoid X receptor, atherosclerosis and metabolic control. Curr Opin Lipidol 2007;18:289-297.
-
(2007)
Curr Opin Lipidol
, vol.18
, pp. 289-297
-
-
Kuipers, F.1
Stroeve, J.H.2
Caron, S.3
Staels, B.4
-
14
-
-
33645531297
-
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
-
Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk TH, Grefhorst A, Abdelkarim M, et al. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 2006;281:11039-11049.
-
(2006)
J Biol Chem
, vol.281
, pp. 11039-11049
-
-
Cariou, B.1
Van Harmelen, K.2
Duran-Sandoval, D.3
Van Dijk, T.H.4
Grefhorst, A.5
Abdelkarim, M.6
-
15
-
-
32244447570
-
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
-
Zhang Y, Lee FY, Barrera G, Lee H, Vales C, Gonzalez FJ, et al. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci USA 2006;103:1006-1011.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 1006-1011
-
-
Zhang, Y.1
Lee, F.Y.2
Barrera, G.3
Lee, H.4
Vales, C.5
Gonzalez, F.J.6
-
16
-
-
0034664729
-
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
-
Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000;102:731-744.
-
(2000)
Cell
, vol.102
, pp. 731-744
-
-
Sinal, C.J.1
Tohkin, M.2
Miyata, M.3
Ward, J.M.4
Lambert, G.5
Gonzalez, F.J.6
-
17
-
-
85047694456
-
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
-
Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Hey-man RA et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 2004;113:1408-1418.
-
(2004)
J Clin Invest
, vol.113
, pp. 1408-1418
-
-
Watanabe, M.1
Houten, S.M.2
Wang, L.3
Moschetta, A.4
Mangelsdorf, D.J.5
Hey-man, R.A.6
-
18
-
-
0033552130
-
Colesevelam hydrochloride (cholestagel): A new, potent bile acid seques-trant associated with a low incidence of gastrointestinal side effects
-
Davidson MH, Dillon MA, Gordon B, Jones P, Samuels J, Weiss S, et al. Colesevelam hydrochloride (cholestagel): a new, potent bile acid seques-trant associated with a low incidence of gastrointestinal side effects. Arch Intern Med 1999;159:1893-1900.
-
(1999)
Arch Intern Med
, vol.159
, pp. 1893-1900
-
-
Davidson, M.H.1
Dillon, M.A.2
Gordon, B.3
Jones, P.4
Samuels, J.5
Weiss, S.6
-
19
-
-
0142211282
-
Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: Efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein
-
Kok T, Hulzebos CV, Wolters H, Havinga R, Agellon LB, Stellaard F, et al. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein. J Biol Chem 2003;278:41930-41937.
-
(2003)
J Biol Chem
, vol.278
, pp. 41930-41937
-
-
Kok, T.1
Hulzebos, C.V.2
Wolters, H.3
Havinga, R.4
Agellon, L.B.5
Stellaard, F.6
-
20
-
-
33748288251
-
Abcg5/Abcg8-independent pathways contribute to hepatobili-ary cholesterol secretion in mice
-
Plosch T, van der Veen JN, Havinga R, Huijkman NC, Bloks VW, Kuipers F. Abcg5/Abcg8-independent pathways contribute to hepatobili-ary cholesterol secretion in mice. Am J Physiol Gastrointest Liver Physiol 2006;291:G414-G423.
-
(2006)
Am J Physiol Gastrointest Liver Physiol
, vol.291
-
-
Plosch, T.1
Van Der Veen, J.N.2
Havinga, R.3
Huijkman, N.C.4
Bloks, V.W.5
Kuipers, F.6
-
21
-
-
33845261493
-
A rapid method of total lipid extraction and purification
-
Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
-
(1959)
Can J Biochem Physiol
, vol.37
, pp. 911-917
-
-
Bligh, E.G.1
Dyer, W.J.2
-
22
-
-
0014857680
-
A fluorimetric and enzymatic method for the estimation of serum total bile acids
-
Murphy GM, Billing BH, Baron DN. A fluorimetric and enzymatic method for the estimation of serum total bile acids. J Clin Pathol 1970;23: 594-598.
-
(1970)
J Clin Pathol
, vol.23
, pp. 594-598
-
-
Murphy, G.M.1
Billing, B.H.2
Baron, D.N.3
-
23
-
-
0035204295
-
Measurement of parameters of cholic acid kinetics in plasma using a microscale stable isotope dilution technique: Application to rodents and humans
-
Hulzebos CV, Renfurm L, Bandsma RH, Verkade HJ, Boer T, Boverhof R, et al. Measurement of parameters of cholic acid kinetics in plasma using a microscale stable isotope dilution technique: application to rodents and humans. J Lipid Res 2001;42:1923-1929.
-
(2001)
J Lipid Res
, vol.42
, pp. 1923-1929
-
-
Hulzebos, C.V.1
Renfurm, L.2
Bandsma, R.H.3
Verkade, H.J.4
Boer, T.5
Boverhof, R.6
-
24
-
-
46349093356
-
Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression
-
Tancevski I, Wehinger A, Demetz E, Eller P, Duwensee K, Huber J, et al. Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression. Endocrinology 2008;149:3708-3712.
-
(2008)
Endocrinology
, vol.149
, pp. 3708-3712
-
-
Tancevski, I.1
Wehinger, A.2
Demetz, E.3
Eller, P.4
Duwensee, K.5
Huber, J.6
-
25
-
-
0033569441
-
Metabolic adaptations to dietary fat malabsorption in chylomicron-deficient mice
-
Jung HR, Turner SM, Neese RA, Young SG, Hellerstein MK. Metabolic adaptations to dietary fat malabsorption in chylomicron-deficient mice. Biochem J 1999;343:473-478.
-
(1999)
Biochem J
, vol.343
, pp. 473-478
-
-
Jung, H.R.1
Turner, S.M.2
Neese, R.A.3
Young, S.G.4
Hellerstein, M.K.5
-
26
-
-
0027530502
-
Measurement of endogenous synthesis of plasma cholesterol in rats and humans using MIDA
-
Neese RA, Faix D, Kletke C, Wu K, Wang AC, Shackleton CH, et al. Measurement of endogenous synthesis of plasma cholesterol in rats and humans using MIDA. Am J Physiol 1993;264:E136-E147.
-
(1993)
Am J Physiol
, vol.264
-
-
Neese, R.A.1
Faix, D.2
Kletke, C.3
Wu, K.4
Wang, A.C.5
Shackleton, C.H.6
-
27
-
-
0037406445
-
Hepatic VLDL production inob/ob mice isnot stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin
-
Wiegman CH, Bandsma RH, Ouwens M, van der Sluijs FH, Havinga R, Boer T, et al. Hepatic VLDL production inob/ob mice isnot stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Diabetes 2003;52:1081-1089.
-
(2003)
Diabetes
, vol.52
, pp. 1081-1089
-
-
Wiegman, C.H.1
Bandsma, R.H.2
Ouwens, M.3
Van Der Sluijs, F.H.4
Havinga, R.5
Boer, T.6
-
28
-
-
67649518181
-
High fat feeding induces hepatic fatty acid elongation in mice
-
Oosterveer MH, van Dijk TH, Tietge UJ, Boer T, Havinga R, Stellaard F, et al. High fat feeding induces hepatic fatty acid elongation in mice. PLoS One 2009;4:e6066.
-
(2009)
PLoS One
, vol.4
-
-
Oosterveer, M.H.1
Van Dijk, T.H.2
Tietge, U.J.3
Boer, T.4
Havinga, R.5
Stellaard, F.6
-
29
-
-
0037072809
-
Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1
-
Plosch T, Kok T, Bloks VW, Smit MJ, Havinga R, Chimini G, et al. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J Biol Chem 2002;277: 33870-33877.
-
(2002)
J Biol Chem
, vol.277
, pp. 33870-33877
-
-
Plosch, T.1
Kok, T.2
Bloks, V.W.3
Smit, M.J.4
Havinga, R.5
Chimini, G.6
-
30
-
-
46749094102
-
Hepatic insulin resistance directly promotes formation of cholesterol gallstones
-
Biddinger SB, Haas JT, Yu BB, Bezy O, Jing E, Zhang W, et al. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med 2008;14:778-782.
-
(2008)
Nat Med
, vol.14
, pp. 778-782
-
-
Biddinger, S.B.1
Haas, J.T.2
Yu, B.B.3
Bezy, O.4
Jing, E.5
Zhang, W.6
-
31
-
-
0036086885
-
Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats
-
van Waarde WM, Verkade HJ, Wolters H, Havinga R, Baller J, Bloks V, et al. Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats. Gastroenterology 2002;122:1842-1852.
-
(2002)
Gastroenterology
, vol.122
, pp. 1842-1852
-
-
Van Waarde, W.M.1
Verkade, H.J.2
Wolters, H.3
Havinga, R.4
Baller, J.5
Bloks, V.6
-
32
-
-
53149108993
-
Transforming growth factor beta1, tumor necrosis factor a, and insulin signaling crosstalk in regulation of the rat cholesterol 7alpha-hydroxylase gene expression
-
LiT,Ma H,Chiang JY. Transforming growth factor beta1, tumor necrosis factor a, and insulin signaling crosstalk in regulation of the rat cholesterol 7alpha-hydroxylase gene expression. J Lipid Res 2008;49:1981-1989.
-
(2008)
J Lipid Res
, vol.49
, pp. 1981-1989
-
-
Litma Hchiang, J.Y.1
-
33
-
-
0025150480
-
Pathophysiology and pathogenesis of cholesterol gallstone formation
-
Hay DW, Carey MC. Pathophysiology and pathogenesis of cholesterol gallstone formation. Semin Liver Dis 1990;10:159-170.
-
(1990)
Semin Liver Dis
, vol.10
, pp. 159-170
-
-
Hay, D.W.1
Carey, M.C.2
-
34
-
-
0033952113
-
Association of diabetes, serum insulin, and C-peptide with gallbladder disease
-
Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. HEPATOLOGY 2000;31:299-303.
-
(2000)
HEPATOLOGY
, vol.31
, pp. 299-303
-
-
Ruhl, C.E.1
Everhart, J.E.2
-
35
-
-
0347895068
-
Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits
-
Xu G, Pan LX, Li H, Forman BM, Erickson SK, Shefer S, et al. Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits. J Biol Chem 2002;277:50491-50496.
-
(2002)
J Biol Chem
, vol.277
, pp. 50491-50496
-
-
Xu, G.1
Pan, L.X.2
Li, H.3
Forman, B.M.4
Erickson, S.K.5
Shefer, S.6
-
36
-
-
33847057732
-
Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin
-
Kobayashi M, Ikegami H, Fujisawa T, Nojima K, Kawabata Y, Noso S, et al. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin. Diabetes 2007;56:239-247.
-
(2007)
Diabetes
, vol.56
, pp. 239-247
-
-
Kobayashi, M.1
Ikegami, H.2
Fujisawa, T.3
Nojima, K.4
Kawabata, Y.5
Noso, S.6
-
37
-
-
27744577847
-
Effects of colestimide and/or Bofu-tsusho-san on plasma and liver lipids in mice fed a high-fat diet
-
Sakamoto S, Takeshita S, Sassa S, Suzuki S, Ishikawa Y, Kudo H. Effects of colestimide and/or Bofu-tsusho-san on plasma and liver lipids in mice fed a high-fat diet. In Vivo 2005;19:1029-1033.
-
(2005)
In Vivo
, vol.19
, pp. 1029-1033
-
-
Sakamoto, S.1
Takeshita, S.2
Sassa, S.3
Suzuki, S.4
Ishikawa, Y.5
Kudo, H.6
-
38
-
-
33646088382
-
Activation of the farnesoid X receptor improves lipid metabolism in combined hyper-lipidemic hamsters
-
Bilz S, Samuel V, Morino K, Savage D, Choi CS, Shulman GI. Activation of the farnesoid X receptor improves lipid metabolism in combined hyper-lipidemic hamsters. Am J Physiol Endocrinol Metab 2006;290:E716-E722.
-
(2006)
Am J Physiol Endocrinol Metab
, vol.290
-
-
Bilz, S.1
Samuel, V.2
Morino, K.3
Savage, D.4
Choi, C.S.5
Shulman, G.I.6
-
39
-
-
22544452537
-
The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition
-
Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, et al. The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J Biol Chem 2005;280:29971-29979.
-
(2005)
J Biol Chem
, vol.280
, pp. 29971-29979
-
-
Duran-Sandoval, D.1
Cariou, B.2
Percevault, F.3
Hennuyer, N.4
Grefhorst, A.5
Van Dijk, T.H.6
-
40
-
-
0942279602
-
Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR
-
Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA. Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 2004;18:157-169.
-
(2004)
Genes Dev
, vol.18
, pp. 157-169
-
-
Zhang, Y.1
Castellani, L.W.2
Sinal, C.J.3
Gonzalez, F.J.4
Edwards, P.A.5
-
41
-
-
33845573067
-
Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase
-
Matsukuma KE, Bennett MK, Huang J, Wang L, Gil G, Osborne TF. Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase. J Lipid Res 2006;47:2754-2761.
-
(2006)
J Lipid Res
, vol.47
, pp. 2754-2761
-
-
Matsukuma, K.E.1
Bennett, M.K.2
Huang, J.3
Wang, L.4
Gil, G.5
Osborne, T.F.6
-
42
-
-
25444512015
-
Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice
-
Grefhorst A, van Dijk TH, Hammer A, van der Sluijs FH, Havinga R, Havekes LM, et al. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am J Physiol Endocrinol Metab 2005;289:E829-E838.
-
(2005)
Am J Physiol Endocrinol Metab
, vol.289
-
-
Grefhorst, A.1
Van Dijk, T.H.2
Hammer, A.3
Van Der Sluijs, F.H.4
Havinga, R.5
Havekes, L.M.6
-
43
-
-
0029800090
-
Zonation of parenchymal and nonparen-chymal metabolism in liver
-
Jungermann K, Kietzmann T. Zonation of parenchymal and nonparen-chymal metabolism in liver. Annu Rev Nutr 1996;16:179-203.
-
(1996)
Annu Rev Nutr
, vol.16
, pp. 179-203
-
-
Jungermann, K.1
Kietzmann, T.2
-
44
-
-
33846970566
-
Differential hepatocellular zonation pattern of cholesterol 7alpha-hydrox-ylase (Cyp7a1) and sterol 12alpha-hydroxylase (Cyp8b1) in the mouse
-
Wang J, Olin M, Rozell B, Bjorkhem I, Einarsson C, Eggertsen G, et al. Differential hepatocellular zonation pattern of cholesterol 7alpha-hydrox-ylase (Cyp7a1) and sterol 12alpha-hydroxylase (Cyp8b1) in the mouse. Histochem Cell Biol 2007;127:253-261.
-
(2007)
Histochem Cell Biol
, vol.127
, pp. 253-261
-
-
Wang, J.1
Olin, M.2
Rozell, B.3
Bjorkhem, I.4
Einarsson, C.5
Eggertsen, G.6
-
45
-
-
0028901070
-
Heterogeneous expression of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase genes in the rat liver lobulus
-
Twisk J, Hoekman MF, Mager WH, Moorman AF, de Boer PA, Scheja L, et al. Heterogeneous expression of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase genes in the rat liver lobulus. J Clin Invest 1995;95: 1235-1243.
-
(1995)
J Clin Invest
, vol.95
, pp. 1235-1243
-
-
Twisk, J.1
Hoekman, M.F.2
Mager, W.H.3
Moorman, A.F.4
De Boer, P.A.5
Scheja, L.6
-
46
-
-
0027082241
-
Hepatocyte heterogeneity in bile formation and hepatobiliary transport of drugs
-
Groothuis GM, Meijer DK. Hepatocyte heterogeneity in bile formation and hepatobiliary transport of drugs. Enzyme 1992;46:94-138.
-
(1992)
Enzyme
, vol.46
, pp. 94-138
-
-
Groothuis, G.M.1
Meijer, D.K.2
|